PepGen (PEPG) Retained Earnings (2021 - 2026)
PepGen (PEPG) reported Retained Earnings of -$378.9 million for Q1 2026, down 1722172.73% on a YoY basis from N/an in Q1 2025, and down 3444645.45% sequentially from $11000.0 in Q4 2025.
PepGen (PEPG) Retained Earnings (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Retained Earnings data on file, last reported at -$378.9 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 1722172.73% year-over-year to -$378.9 million; the trailing twelve-month figure through Mar 2026 stood at -$378.9 million (down 1722172.73% YoY), and the FY2025 full-year result was $11000.0, down 52.17% from the prior year.
- Retained Earnings fell to -$378.9 million in Q1 2026, from $11000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $23000.0 in Q4 2024 to a low of -$378.9 million in Q1 2026.
- A 5-year average of -$124.7 million and a median of -$87.9 million in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings surged 100.01% in 2024 and slumped 1722172.73% in 2026, its largest moves.
- Tracing PEPG's Retained Earnings over 5 years: stood at -$81000.0 in 2022, then sank by 223951.85% to -$181.5 million in 2023, then soared by 100.01% to $23000.0 in 2024, then sank by 52.17% to $11000.0 in 2025, then sank by 3444645.45% to -$378.9 million in 2026.
- Business Quant data shows PEPG's Retained Earnings at -$378.9 million in Q1 2026, $11000.0 in Q4 2025, and -$342.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | -378.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -378.90 Mn |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | -342.78 Mn |
| Jun 30, 2025 | -324.75 Mn |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Sep 30, 2024 | -249.20 Mn |
| Jun 30, 2024 | -227.80 Mn |
| Mar 31, 2024 | -37,000.00 |
| Dec 31, 2023 | -181.48 Mn |
| Sep 30, 2023 | -57,000.00 |
| Jun 30, 2023 | -138.70 Mn |
| Mar 31, 2023 | -119.20 Mn |
| Dec 31, 2022 | -81,000.00 |
| Sep 30, 2022 | -87.92 Mn |
| Jun 30, 2022 | -69.31 Mn |
| Mar 31, 2022 | -57,000.00 |
| Dec 31, 2021 | 17,000.00 |